June 6, 2011Date Released: 6 June 2011
CASE CCC IN THE NEWS
Improved Technology Helps Make Care More Efficient at Seidman
Genomic Health Presents Ten New Studies in Breast, Colon and Prostate Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting
AXIS 1032: Axitinib Associated With Extended PFS in Metastatic RCC
Study Finds Vaccine Extends Recurrent GBM Survival Rates by 2 to 3 Times
Using Your Cell Phone Could Be Leading You to a Slow Death
CASE CCC ANNUAL SCIENTIFIC RETREATCall for Abstracts: Cancer-Related Research
July 8-9, 2011
The Case CCC Annual Scientific Retreat will be held July 8-9, 2011 at Corporate College East. The evening of July 8 will feature a poster presentation session. All graduate students, postdocs and fellows conducting cancer research are invited to submit abstracts. The Retreat Program Committee will review abstracts based on the relationship to cancer, novelty, significance of findings, and clarity. Monetary prizes will be awarded. More information is available on the Call for Abstracts page.
The deadline to submit abstracts to email@example.com is Tuesday, June 7 at 5 pm.
Watch our website for updates. Registration is now open!
FUNDING OPPORTUNITIESAACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research
The AACR-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research is given to a scientist residing in any country in the world for his or her seminal contributions to the field of cancer prevention. Such investigations must have been conducted in basic, translational, clinical, epidemiological, or behavioral science in cancer prevention research. Further, these studies must have had not only a major impact on the field, but must also have stimulated new directions in this important area.
Deadline: June 13Pilot Project Grants: American Cancer Society IRG Awards
The Case CCC is currently accepting applications for American Cancer Society Institutional Research Grant (IRG) awards. Pilot funding is available for projects in basic, clinical, prevention and control, behavioral, health services, and epidemiology cancer research with awards up to $30,000 for one-year cancer research projects that provide the basis for future independent grants.
Instructions, frequently asked questions, and application forms are available at http://cancer.case.edu. Contact Terri Daso, Cancer Center Administration (844-7252,firstname.lastname@example.org) for more information.
LOI Deadline: June 13
The Case Comprehensive Cancer Center is announcing the availability of Protocol Specific Research Support (PSRS) funding for Year 2011. The budgeted funds are for the conduct of early phase clinical trial and restricted to support research nurses and data managers directly involved in the conduct of these clinical trials. Studies developed jointly between UH and CCF with planned accrual at both institutions will be prioritized. Please direct questions and requests for information about the funding process to Katarzyna Karelus, Administrative Director, Case Comprehensive Cancer Center Clinical Research Office, at (216) 368-6287 email@example.com.
ANNOUNCEMENTSLee Ponsky Receives 2011 Leonard Tow Humanism in Medicine Award
Lee Ponsky, MD, Associate Professor of Urology, and Satoko Kanahara, fourth year medical student at CCLCM, have received the 2011 Leonard Tow Humanism in Medicine Award presented by the Arnold P. Gold Foundation. The award is given annually to one faculty member and one graduating medical student for exemplifying outstanding humanism in medicine and scientific excellence.New Continuing Review Form for Retrospective Chart Reviews
The Cancer IRB has a new form for Continuing Reviews that can be used for Chart Review research. Please share this message with all users currently conducting chart review research by the Case Cancer IRB. Please contact Mariesa Malinowski, Administrative Director, Case Cancer IRB, with any questions.Call for Applications: Merrill J. Egorin Workshop in Cancer Pharmacology
The Cancer Education Consortium is pleased to announce its annual workshop to be held September 23-26 in Leesburg, Virginia. This 3-day interactive workshop offers a broad-based curriculum that covers a range of topics related to new drug development and clinical evaluation. Expert speakers will lead discussions and present important didactic information regarding the preclinical and clinical evaluation of cytotoxic and targeted drugs, the identification and use of biomarkers, the special challenges of evaluating combination therapies, the problem of pharmacodynamic and pharmacokinetic drug interactions, and effects of organ dysfunction on drug disposition and toxicity. The discussion will include a focus on validation of targets and confirmation of mechanism of action and resistance in clinical trials. The 20-25 scholars selected will have ample opportunity for one-on-one interface with the nationally renowned faculty as well as peer-to-peer networking. Specialized evening workshops will also include sessions on new drugs, utility of biomarkers for selection of subjects and for prediction of response, and late breaking developments in cancer therapeutics.
Application Deadline: June 13
NCI CANCER BULLETINMay 31, 2011
**All events are open to anyone interested in attending
Hematology and Oncology Division Research Conference
2011 Louis A. Bloomfield Lecture
Hematology/Oncology Fellows Seminar
Taussig Cancer Institute Grand Rounds
Cell Biology Seminar Series
Cancer Center Research in Progress Seminar
Case CCC Calendar
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS
ASCO Review 2011
Case CCC Annual Scientific Retreat
ADDITIONAL UPCOMING SEMINARS & EVENTS
International Society for Stem Cell Research (ISSCR) Annual Meeting
Cancer Health Disparities Summit 2011
8th International Conference of the Society for Integrative Oncology: Innovating Integrative Oncology: New Science, New Solutions
PREVIOUSLY ANNOUNCED OPPORTUNITIES
DOD CDMRP Breast Cancer Research Program Idea Award
DOD CDMRP Prostate Cancer Research Program Impact Award
NIH BULLETIN – Notices and Funding Opportunities
Community Clinical Oncology Program Groups (U10) (RFA-CA-11-006)
Community Clinical Oncology Program Research Bases (U10) (RFA-CA-11-007)
Minority-Based Community Clinical Oncology Program Groups (U10) (RFA-CA-11-008)
Cancer Target Discovery and Development (CTDD) Network (U01) (RFA-CA-11-010)
Technology Development for High-Throughput Functional Genomics (R01) (RFA-HG-11-013)
Technology Development for High-Throughput Functional Genomics (R21) (RFA-HG-11-014)
Technology Development for High-Throughput Functional Genomics (R43/44) (RFA-HG-11-015)
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21) (PAR-11-216)
HELP US HELP YOU!
If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades!
Send items to firstname.lastname@example.org.